Public-sector Contributions to Novel Biologic Drugs.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34279545.
- Also identified by DOI 10.1001/jamainternmed.2021.3720 and PMC identifier 8290329.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study investigates downstream public-sector support for the creation of new biologic drugs by examining their patent and drug development histories.
Medical subject headings
- Biological Products
- Drug Approval
- Drug Development
- Public Sector